Welcome guest, Sign in

Home

X
加载中

Clostridium difficile (a Gram-positive, spore-forming, strict anaerobe) can colonize antibiotic-treated hosts (McFarland, 2008). Antibiotics alter the composition of the normal, benign microbial flora which leads to loss of colonization resistance (Wilson and Perini, 1988; Antonopoulos et al., 2009). C. difficile spores germinate to actively growing bacteria which secrete toxins that damage the colonic epithelium (Voth and Ballard, 2005). The use of animal models of C. difficile disease have allowed the identification of mechanisms of colonization and virulence factors (Lyras et al., 2009; Kuehne et al., 2010; Francis et al., 2013; Aubry et al., 2012; Carter et al., 2011). This protocol describes virulence studies of C. difficile in the hamster model of C. difficile infection (Bartlett et al., 1978; Sambol et al., 2001).

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Virulence Studies of Clostridium difficile

Microbiology > Microbe-host interactions > In vivo model > Mammal
Authors: Michael B. Francis
Michael B. Francis Affiliation: Department of Biology, Texas A&M University, College Station, USA
Bio-protocol author page: a1067
 and Joseph A. Sorg
Joseph A. SorgAffiliation: Department of Biology, Texas A&M University, College Station, USA
For correspondence: jsorg@bio.tamu.edu
Bio-protocol author page: a1069
Vol 3, Iss 24, 12/20/2013, 2266 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1002

[Abstract] Clostridium difficile (a Gram-positive, spore-forming, strict anaerobe) can colonize antibiotic-treated hosts (McFarland, 2008). Antibiotics alter the composition of the normal, benign microbial flora which leads to loss of colonization resistance (Wilson and Perini, 1988; Antonopoulos et al., 2009). C. difficile spores germinate to actively growing bacteria which secrete toxins that damage the colonic epithelium (Voth and Ballard, 2005). The use of animal models of C. difficile disease have allowed the identification of mechanisms of colonization and virulence factors (Lyras et al., 2009; Kuehne et al., 2010; Francis et al., 2013; Aubry et al., 2012; Carter et al., 2011). This protocol describes virulence studies of C. difficile in the hamster model of C. difficile infection (Bartlett et al., 1978; Sambol et al., 2001).

Keywords: Clostridium difficile, Spore, Virulence, Hamster, Animal model

Materials and Reagents

  1. Institutional Animal Care and Use Committee (IACUC)-approved animal use protocol
  2. C. difficile spores
  3. Female Syrian golden hamsters (80 g–120 g)
  4. Clindamycin Injection, USP (150 mg/ml) (Hospira, catalog number: 0409-4052)
  5. Dulbecco’s Modified Eagle Medium (DMEM)

Equipment

  1. Animal feeding needles (gavage needles)
  2. 1 ml syringe
  3. Dedicated BSL2 animal facility
  4. Scale

Procedure

  1. Weigh each hamster.
  2. Gavage 100 μl clindamycin to each hamster (30 mg clindamycin / kg body weight).
    Note: Dilute the stock clindamycin to the appropriate concentration using DMEM.
  3. After 5 days, gavage 100 μl C. difficile spores.
    Notes:
    1. Depending on the strain of C. difficile used, the infectious dose can vary. However, in several strains, inoculation with approximately 100 spores will result in lethal disease.
    2. There are several methods to ensure reproducible infectious doses [e.g. suspending spores in phosphate buffered saline (PBS)]. Our laboratory uses Teflon-coated tubes to reduce spore adherence. Other laboratories can get reproducible infectious doses in water.
  4. Closely monitor animals for signs of infection including: wet tail, poor fur coat, lethargy, loss of 15% body weight.
    Note: Signs of disease are commonly observed in 2 – 4 days post infection. Be sure to closely monitor the animals for the above symptoms. Moribund animals can succumb to disease quickly.
  5. Humanly euthanize moribund animals, in accordance with your protocol that was approved by your Institutional Care and Animal Use Committee (IACUC). Score the time required to reach a moribund state.

Acknowledgments

We would like to thank Charlotte Allen and Ritu Shrestha for aiding in the development of this protocol. This protocol is based upon previously published C. difficile virulence studies by Sambol et al. (2001), wherein the authors analyzed the infection of hamsters by epidemiologically important C. difficile isolates. This work was supported by the American Heart Association National Scientist Development grant to JAS (No. 11SDG7160013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  1. Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L. and Young, V. B. (2009). Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77(6): 2367-2375.
  2. Aubry, A., Hussack, G., Chen, W., KuoLee, R., Twine, S. M., Fulton, K. M., Foote, S., Carrillo, C. D., Tanha, J. and Logan, S. M. (2012). Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect Immun 80(10): 3521-3532.
  3. Bartlett, J. G., Chang, T. W., Moon, N. and Onderdonk, A. B. (1978). Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res 39(9): 1525-1530.
  4. Carter, G. P., Douce, G. R., Govind, R., Howarth, P. M., Mackin, K. E., Spencer, J., Buckley, A. M., Antunes, A., Kotsanas, D., Jenkin, G. A., Dupuy, B., Rood, J. I. and Lyras, D. (2011). The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog 7(10): e1002317.
  5. Francis, M. B., Allen, C. A., Shrestha, R. and Sorg, J. A. (2013). Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog 9(5): e1003356.
  6. Kuehne, S. A., Cartman, S. T., Heap, J. T., Kelly, M. L., Cockayne, A. and Minton, N. P. (2010). The role of toxin A and toxin B in Clostridium difficile infection. Nature 467(7316): 711-713.
  7. Lyras, D., O'Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., Gerding, D. N. and Rood, J. I. (2009). Toxin B is essential for virulence of Clostridium difficile. Nature 458(7242): 1176-1179.
  8. McFarland, L. V. (2008). Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5(1): 40-48.
  9. Sambol, S. P., Tang, J. K., Merrigan, M. M., Johnson, S. and Gerding, D. N. (2001). Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 183(12): 1760-1766.
  10. Voth, D. E. and Ballard, J. D. (2005). Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18(2): 247-263.
  11. Wilson, K. H. and Perini, F. (1988). Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56(10): 2610-2614.


How to cite this protocol: Francis, M. B. and Sorg, J. A. (2013). Virulence Studies of Clostridium difficile. Bio-protocol 3(24): e1002. DOI: 10.21769/BioProtoc.1002; Full Text



Share Your Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook